Short Interest in Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Increases By 1,033.0%

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) saw a significant growth in short interest in February. As of February 13th, there was short interest totaling 32,799 shares, a growth of 1,033.0% from the January 29th total of 2,895 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 59,321 shares, the short-interest ratio is currently 0.6 days. Based on an average daily volume of 59,321 shares, the short-interest ratio is currently 0.6 days. Approximately 0.0% of the company’s stock are short sold.

Cardiac Biotech Solutions Stock Performance

OTCMKTS:CBSC remained flat at $0.04 during trading hours on Friday. The company had a trading volume of 211,999 shares, compared to its average volume of 18,516. The stock has a fifty day moving average price of $0.04 and a two-hundred day moving average price of $0.04. Cardiac Biotech Solutions has a 52-week low of $0.02 and a 52-week high of $0.10.

Cardiac Biotech Solutions Company Profile

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Read More

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.